Abstract :

Monkey pox is one of the most rare disease caused by the infection of monkey pox virus; the source of disease still remained unknown. It was discovered in 1958 where there is an outbreak in small-pox like disease. At that time monkey were kept to further analyze. In 1970, the first instance of monkeypox in a human was noted. Monkeypox cases have now been documented in a number of other central and western African nations. Prior to the 2022 outbreak, almost all cases of monkeypox in people outside of Africa were connected to either imported animals or foreign travel to nations where the illness frequently occurs. There are various symptoms that could be diagnosed as the monkey pox. The most common ones are the rash which is identical to pimples of blisters that appear on our face regularly. However, it may spread towards other part of our body including the hands, feet, chest, genitals, or anus. The monkey pox rash has different stages starting from the ones identical to pimples to the burned out. This illness typically last between 2-4 weeks. SInce the monkey pox disease is not as common, researchers is still currently work on discovering the root cause. In the present, there is still not enough resources available.

---

Keywords :

Mokeypox, Monkeypox virus, Orthopoxvirus, Variola viruses

---

References :

1. Essbauer and H. Meyer, “Genus Orthopoxvirus: Monkeypox virus,” in Poxviruses: Springer, 2007, pp. 65-73.
2. Memariani and H. Memariani, “Multinational monkeypox outbreak: what do we know and what should we do?,” Irish Journal of Medical Science (1971-), pp. 1-2, 2022.
3. Formenty et al., “Human monkeypox outbreak caused by novel virus belonging to Congo Basin clade, Sudan, 2005,” Emerging infectious diseases, vol. 16, no. 10, p. 1539, 2010.
4. M. Likos et al., “A tale of two clades: monkeypox viruses,” Journal of General Virology, vol. 86, no. 10, pp. 2661-2672, 2005.
5. Meyer, R. Ehmann, and G. L. Smith, “Smallpox in the post-eradication era,” Viruses, vol. 12, no. 2, p. 138, 2020.
6. T. Russo et al., “An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications,” Expert Review of Anti-infective Therapy, vol. 19, no. 3, pp. 331-344, 2021.
7. Yang, “Monkeypox: a potential global threat?,” Journal of Medical Virology, 2022.
8. -Y. Nguyen, W. S. Ajisegiri, V. Costantino, A. A. Chughtai, and C. R. MacIntyre, “Reemergence of human monkeypox and declining population Immunity in the context of urbanization, Nigeria, 2017–2020,” Emerging Infectious Diseases, vol. 27, no. 4, p. 1007, 2021.
9. L. Hutson et al., “A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus,” Journal of General Virology, vol. 90, no. 2, pp. 323-333, 2009.
10. L. Hutson et al., “Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease,” Virology, vol. 402, no. 1, pp. 72-82, 2010.
11. Parker, A. Nuara, R. M. L. Buller, and D. A. Schultz, “Human monkeypox: an emerging zoonotic disease,” 2007.
12. World Health, “Surveillance, case investigation and contact tracing for monkeypox: interim guidance, 22 May 2022,” World Health Organization, 2022.
13. W. Petersen et al., “Vaccinating against monkeypox in the Democratic Republic of the Congo,” Antiviral research, vol. 162, pp. 171-177, 2019.
14. K. Mbala et al., “Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo,” The Journal of infectious diseases, vol. 216, no. 7, pp. 824-828, 2017.
15. A. Falendysz et al., “Further assessment of monkeypox virus infection in Gambian pouched rats (Cricetomys gambianus) using in vivo bioluminescent imaging,” PLoS neglected tropical diseases, vol. 9, no. 10, p. e0004130, 2015.
16. H. Diaz, “The disease ecology, epidemiology, clinical manifestations, management, prevention, and control of increasing human infections with animal orthopoxviruses,” Wilderness & Environmental Medicine, vol. 32, no. 4, pp. 528-536, 2021.
17. Vaughan et al., “Human-to-human transmission of monkeypox virus, United Kingdom, October 2018,” Emerging infectious diseases, vol. 26, no. 4, p. 782, 2020.
18. V. Patrono et al., “Monkeypox virus emergence in wild chimpanzees reveals distinct clinical outcomes and viral diversity,” Nature Microbiology, vol. 5, no. 7, pp. 955-965, 2020.
19. M. Gigante et al., “Multiple lineages of Monkeypox virus detected in the United States, 2021-2022,” bioRxiv, 2022.
20. Zhang, J.-Y. Zhang, and F.-S. Wang, “Monkeypox outbreak: A novel threat after COVID-19?,” Military Medical Research, vol. 9, no. 1, pp. 1-3, 2022.
21. Makkar, “The Latest News for May 2022 All You Need to Know on Mon-keypox,” 2022.
22. Berthet et al., “Genomic history of human monkey pox infections in the Central African Republic between 2001 and 2018,” Scientific reports, vol. 11, no. 1, pp. 1-11, 2021.
23. Sklenovská, “Monkeypox Virus,” in Animal-Origin Viral Zoonoses: Springer, 2020, pp. 39-68.
24. T. Russo et al., “Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge,” Vaccine, vol. 38, no. 3, pp. 644-654, 2020.
25. M. Beer and V. B. Rao, “A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy,” PLoS neglected tropical diseases, vol. 13, no. 10, p. e0007791, 2019.
26. Antinori et al., “Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022,” Eurosurveillance, vol. 27, no. 22, p. 2200421, 2022.
27. P. Gomes et al., “Multi-country outbreak of monkeypox virus: phylogenomic characterization and signs of microevolution,” 2022.
28. R. Assessment, “Monkeypox multi-country outbreak,” 2022.
29. A. Adegboye et al., “Travel-Related Monkeypox Outbreaks in the Era of COVID-19 Pandemic: Are We Prepared?,” Viruses, vol. 14, no. 6, p. 1283, 2022.
30. K. Ibrahim and M. A. Shemis, “Monkeypox virus: a worldwide new emerging problem,” sexual health, vol. 1, p. 2.
31. Girometti et al., “Epidemiological Characteristics and Clinical Features of Confirmed Human Monkeypox Virus Cases in Individuals Attending a Sexual Health Centre in London, United Kingdom.”
32. Jahanbin, M. Jokar, and V. Rahmanian, “Using twitter and web news mining to predict the monkeypox outbreak,” Asian Pacific Journal of Tropical Medicine, vol. 15, no. 5, p. 236, 2022.
33. P. Velavan and C. G. Meyer, “Monkeypox 2022 outbreak: an update,” Tropical Medicine & International Health, 2022.
34. G. Reynolds et al., “Clinical manifestations of human monkeypox influenced by route of infection,” The Journal of infectious diseases, vol. 194, no. 6, pp. 773-780, 2006.
35. Stabenow, R. M. Buller, J. Schriewer, C. West, J. E. Sagartz, and S. Parker, “A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus,” Journal of virology, vol. 84, no. 8, pp. 3909-3920, 2010.
36. Sklenovska and M. Van Ranst, “Emergence of monkeypox as the most important orthopoxvirus infection in humans,” Frontiers in public health, vol. 6, p. 241, 2018.
37. L. Hutson et al., “Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model,” MSphere, vol. 6, no. 1, pp. e00927-20, 2021.
38. A. J. Guagliardo et al., “Asymptomatic orthopoxvirus circulation in humans in the wake of a monkeypox outbreak among chimpanzees in Cameroon,” The American journal of tropical medicine and hygiene, vol. 102, no. 1, p. 206, 2020.
39. Haider et al., “Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs,” International Journal of Infectious Diseases, 2022.
40. Pal, F. Mengstie, and V. Kandi, “Epidemiology, Diagnosis, and Control of Monkeypox Disease: A comprehensive Review,” American Journal of Infectious Diseases and Microbiology, vol. 5, no. 2, pp. 94-9, 2017.
41. G. Reynolds, J. B. Doty, A. M. McCollum, V. A. Olson, and Y. Nakazawa, “Monkeypox re-emergence in Africa: a call to expand the concept and practice of One Health,” Expert review of anti-infective therapy, vol. 17, no. 2, pp. 129-139, 2019.
42. I. Kabuga and M. E. El Zowalaty, “A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria,” Journal of Medical Virology, vol. 91, no. 4, pp. 533-540, 2019.
43. Wardiana, R. Rahmadewi, D. Murtiastutik, S. Sawitri, and D. Damayanti, “Chickenpox Mimicking Monkeypox in Adult with Diabetes Mellitus and Acute Kidney Injury: Diagnosis and Management,” Berkala Ilmu Kesehatan Kulit dan Kelamin, vol. 33, no. 3, pp. 213-223, 2021.
44. Brown and P. A. Leggat, “Human monkeypox: current state of knowledge and implications for the future,” Tropical medicine and infectious disease, vol. 1, no. 1, p. 8, 2016.
45. Mande et al., “Enhanced surveillance of monkeypox in Bas-Uélé, Democratic Republic of Congo: the limitations of symptom-based case definitions,” medRxiv, 2022.
46. H. Doshi et al., “Epidemiologic and ecologic investigations of monkeypox, Likouala Department, Republic of the Congo, 2017,” Emerging Infectious Diseases, vol. 25, no. 2, p. 273, 2019.
47. G. Reynolds, A. M. McCollum, B. Nguete, R. Shongo Lushima, and B. W. Petersen, “Improving the care and treatment of monkeypox patients in low-resource settings: applying evidence from contemporary biomedical and smallpox biodefense research,” Viruses, vol. 9, no. 12, p. 380, 2017.
48. Parker and R. M. Buller, “A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012,” Future virology, vol. 8, no. 2, pp. 129-157, 2013.
49. -A. M. Mandja and J.-P. Gonzalez, “Unveiling the Arcane of an Elusive Virus from the Heart of the African Continent: The Monkeypox,” in Human Viruses: Diseases, Treatments and Vaccines: Springer, 2021, pp. 477-499.
50. Delaune and F. Iseni, “Drug development against smallpox: present and future,” Antimicrobial Agents and Chemotherapy, vol. 64, no. 4, pp. e01683-19, 2020.
51. F. Johnson et al., “Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route,” Journal of virology, vol. 85, no. 5, pp. 2112-2125, 2011.
52. Dumont et al., “Simple technique for in field samples collection in the cases of skin rash illness and subsequent PCR detection of orthopoxviruses and varicella zoster virus,” PloS one, vol. 9, no. 5, p. e96930, 2014.
53. Saijo et al., “Diagnosis and assessment of monkeypox virus (MPXV) infection by quantitative PCR assay: differentiation of Congo Basin and West African MPXV strains,” Japanese journal of infectious diseases, vol. 61, no. 2, p. 140, 2008.
54. Li, V. A. Olson, T. Laue, M. T. Laker, and I. K. Damon, “Detection of monkeypox virus with real-time PCR assays,” Journal of Clinical Virology, vol. 36, no. 3, pp. 194-203, 2006.
55. Hammerschlag et al., “Monkeypox infection presenting as genital rash, Australia, May 2022,” Eurosurveillance, vol. 27, no. 22, p. 2200411, 2022.
56. F. Gallardo-Romero et al., “Use of live Variola virus to determine whether CAST/EiJ mice are a suitable surrogate animal model for human smallpox,” Virus Research, vol. 275, p. 197772, 2020.
57. T. Lima et al., “An update on the known host range of the Brazilian vaccinia virus: an outbreak in buffalo calves,” Frontiers in Microbiology, vol. 9, p. 3327, 2019.
58. El-Jesr, M. Teir, and C. Maluquer de Motes, “Vaccinia virus activation and antagonism of cytosolic DNA sensing,” Frontiers in Immunology, vol. 11, p. 568412, 2020.
59. Karumathil, N. T. Raveendran, D. Ganesh, S. Kumar Ns, R. R. Nair, and V. R. Dirisala, “Evolution of synonymous codon usage bias in west African and central African strains of monkeypox virus,” Evolutionary Bioinformatics, vol. 14, p. 1176934318761368, 2018.
60. Maluquer de Motes, “Poxvirus cGAMP nucleases: Clues and mysteries from a stolen gene,” PLoS Pathogens, vol. 17, no. 3, p. e1009372, 2021.
61. Alakunle, U. Moens, G. Nchinda, and M. I. Okeke, “Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution,” Viruses, vol. 12, no. 11, p. 1257, 2020.
62. R. Pittman et al., “Clinical characterization of human monkeypox infections in the Democratic Republic of the Congo,” medRxiv, 2022.
63. D. Estep et al., “Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection,” Journal of virology, vol. 85, no. 18, pp. 9527-9542, 2011.
64. Park et al., “Orthopoxvirus K3 orthologs show virus-and host-specific inhibition of the antiviral protein kinase PKR,” PLoS pathogens, vol. 17, no. 1, p. e1009183, 2021.
65. Parker et al., “A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge,” Antiviral Research, vol. 195, p. 105179, 2021.
66. Yu and S. M. Raj, “Efficacy of three key antiviral drugs used to treat orthopoxvirus infections: a systematic review,” Global Biosecurity, vol. 1, no. 1, 2019.
67. D. Davi et al., “Recombinase polymerase amplification assay for rapid detection of Monkeypox virus,” Diagnostic Microbiology and Infectious Disease, vol. 95, no. 1, pp. 41-45, 2019.
68. G. Ademowo, F. T. Hufert, C.-P. Czerny, and A. Abd El Wahed, “Recombinase polymerase amplification assay for rapid detection of Monkeypox virus,” 2019.